AI-enabled algorithms are transforming diabetes care by predicting nighttime lows up to 7 hours in advance. Real-world data shows a 31% drop in severe hypoglycemia, offering proactive safety and peace of mind.
Roche’s nanopore-based sensor module is the electronic heart of sequencing by expansion (SBX). The module contains eight million microscopic wells, each one spanned by a thin membrane with a single nanopore through which a single molecule can pass.
Roche researchers are working on diagnostic innovations to improve the Alzheimer’s patient journey. One of the most promising areas is the development of simple, accurate blood technologies that can detect key biomarkers associated with the disease.
In February 2026, Roche opened its new Diagnostics Innovation Center in Penzberg, Germany. Roche is establishing a modern and sustainable research and development center for approximately 1,000 employees.
Read the perspectives of two Roche leaders on their work in breast cancer – from cutting edge diagnostics to ensuring that all women have equal access to care.